Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.36)
# 3,560
Out of 4,996 analysts
10
Total ratings
50%
Success rate
-0.45%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEN Repligen | Upgrades: Outperform | $130 → $155 | $125.61 | +23.40% | 3 | Sep 22, 2025 | |
| RMBS Rambus | Maintains: Outperform | $81 → $114 | $102.62 | +11.09% | 1 | Sep 16, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $113.87 | +36.12% | 1 | Sep 16, 2025 | |
| INSP Inspire Medical Systems | Initiates: Outperform | $150 | $77.24 | +94.20% | 1 | Sep 2, 2025 | |
| NTRA Natera | Initiates: Outperform | $170 | $162.97 | +4.31% | 1 | Jul 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $275 → $350 | $261.52 | +33.83% | 2 | Jul 25, 2025 | |
| TECH Bio-Techne | Initiates: Outperform | $75 | $51.84 | +44.68% | 1 | Mar 18, 2025 |
Repligen
Sep 22, 2025
Upgrades: Outperform
Price Target: $130 → $155
Current: $125.61
Upside: +23.40%
Rambus
Sep 16, 2025
Maintains: Outperform
Price Target: $81 → $114
Current: $102.62
Upside: +11.09%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $113.87
Upside: +36.12%
Inspire Medical Systems
Sep 2, 2025
Initiates: Outperform
Price Target: $150
Current: $77.24
Upside: +94.20%
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $162.97
Upside: +4.31%
West Pharmaceutical Services
Jul 25, 2025
Maintains: Outperform
Price Target: $275 → $350
Current: $261.52
Upside: +33.83%
Bio-Techne
Mar 18, 2025
Initiates: Outperform
Price Target: $75
Current: $51.84
Upside: +44.68%